Socioeconomical deprivation persists in clinical trials for cancer patients

Written by Ryan Gilroy (Future Science Group)

cancer cell, cancer, oncology

Results from a Southwest Oncology Group (SWOG) Cancer Research Network (OR, USA)┬ástudy highlight how socioeconomically deprived cancer patients, even with access to a clinical trial, have a 28% greater chance of dying from their disease compared to the most affluent patients. Published in the Journal of Clinical Oncology, the findings illustrate the association between socioeconomic deprivation and outcomes among cancer trial patients. This study builds upon work from 2018, that demonstrated that differences in survival rates between rural and urban cancer patients are significantly reduced when patients are enrolled in a clinical trial. “Joining a clinical trial guarantees uniform, high...

To view this content, please register now for access

It's completely free